Documented batches Public COA verification Research use only Quality standards
Primal Platform
← Back to all peptide profiles
Endogenous peptide Clinical data Human data available

Peptide database · P-002

Thymosin beta-4

Tβ4; TMSB4X

Thymosin beta-4 is an endogenous actin-binding peptide investigated in cell migration, cytoskeletal organisation and tissue repair.

01

Molecular profile

Molecular profile

Molecule class
Endogenous peptide
Origin
Endogenous
Primary target system
G-Aktin-Bindung, Zellmigration und Gewebeorganisation
Development stage
Clinical development
Structure note

Natürlich vorkommendes, aktinbindendes Peptid.

02

Mechanism and signalling

Mechanism and signalling

The peptide binds monomeric actin and thereby influences cytoskeletal dynamics. Anti-inflammatory and pro-migratory effects are also under investigation.

03

Scientific classification

Scientific classification

This profile maps Thymosin beta-4 to the research areas regeneration, dermatology. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.

Tissue and regeneration research

Peptides studied in models of cell migration, matrix organisation, wound healing and tissue repair.

Dermatology and melanocortin research

Skin matrix, pigmentation biology, copper peptides and melanocortin signalling.

04

Evidence base

Clinical data

PreclinicalEarly human dataClinical dataPhase IIPhase IIIApproval and post-marketing data

Alongside extensive preclinical research, clinical programmes have investigated ocular and dermal settings. Findings depend on indication and formulation.

05

Regulatory status

Investigational substance

Investigational substance

The substance remains in clinical development and is not authorised as a generally available medicine. Trial status and regulatory assessment may change.

06

Safety and use notice

No dosing or administration recommendation

The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.

07

Sources and registries

Sources and registries